Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02316340
Title Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center at San Antonio
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Therapy and Research Center University of Texas Health Science Center San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field